Dandan Liang
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Molecular Medicine top 10%
-
- Mitochondrial Function and Pathology 7
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
- Metabolomics and Mass Spectrometry Studies 4
- Cell death mechanisms and regulation 4
- ATP Synthase and ATPases Research 4
- Congenital heart defects research 3
- Toxicology top 10%
-
- Renal Diseases and Glomerulopathies 3
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dandan Liang
37 papers receiving 841 citations
Peers
Comparison fields: 5 of 107
- Cancer Research 208
- Molecular Medicine 53
- Molecular Biology 555
- Toxicology 20
- Cardiology and Cardiovascular Medicine 127
Countries citing papers authored by Dandan Liang
This map shows the geographic impact of Dandan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Liang more than expected).
Fields of papers citing papers by Dandan Liang
This network shows the impact of papers produced by Dandan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Liang. The network helps show where Dandan Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dandan Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 35 | |
| 10 | 2020 | 2 | |
| 11 | 2018 | 21 | |
| 12 | 2015 | 83 | |
| 13 | 2015 | 47 | |
| 14 | 2014 | 21 | |
| 15 | 2014 | 15 | |
| 16 | 2014 | 34 | |
| 17 | 2014 | 49 | |
| 18 | 2011 | 9 | |
| 19 | 2010 | 12 | |
| 20 | 2010 | 31 |
About Dandan Liang
Dandan Liang is a scholar working on Molecular Biology, Immunology and Allergy and Nephrology, having authored 39 papers that have together received 853 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Cell death mechanisms and regulation (4 papers), ATP Synthase and ATPases Research (4 papers), Congenital heart defects research (3 papers), MicroRNA in disease regulation (3 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Cancer Research (208 citations), Molecular Medicine (53 citations) and Molecular Biology (555 citations). Dandan Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yihan Chen, Yunfu Sun, Yi Liu, Xingqun Liang, Guang Liang, Junjie Xiao, Tianlu Chen, Yi-Han Chen, Lei Pan and Luying Peng. Their work appears in journals such as Nature Communications, Bioinformatics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.